Product NDC: | 0703-9402 |
Proprietary Name: | Tobramycin sulfate |
Non Proprietary Name: | Tobramycin sulfate |
Active Ingredient(s): | 40 mg/mL & nbsp; Tobramycin sulfate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-9402 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA063100 |
Marketing Category: | ANDA |
Start Marketing Date: | 19920201 |
Package NDC: | 0703-9402-04 |
Package Description: | 25 VIAL in 1 TRAY (0703-9402-04) > 2 mL in 1 VIAL (0703-9402-01) |
NDC Code | 0703-9402-04 |
Proprietary Name | Tobramycin sulfate |
Package Description | 25 VIAL in 1 TRAY (0703-9402-04) > 2 mL in 1 VIAL (0703-9402-01) |
Product NDC | 0703-9402 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Tobramycin sulfate |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19920201 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | TOBRAMYCIN SULFATE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |